BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23240675)

  • 1. Problematic issues in the staging of endometrial, cervical and vulval carcinomas.
    Hirschowitz L; Nucci M; Zaino RJ
    Histopathology; 2013 Jan; 62(1):176-202. PubMed ID: 23240675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of the revised international federation of gynecology and obstetrics staging system 2009].
    Shen K; Peng P; Wu M
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):721-4. PubMed ID: 21176549
    [No Abstract]   [Full Text] [Related]  

  • 3. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant variation in the assessment of cervical involvement in endometrial carcinoma: an interobserver variation study.
    McCluggage WG; Hirschowitz L; Wilson GE; Oliva E; Soslow RA; Zaino RJ
    Am J Surg Pathol; 2011 Feb; 35(2):289-94. PubMed ID: 21263250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sentinel node in gynaecological malignancies.
    Balega J; Van Trappen PO
    Cancer Imaging; 2006 Feb; 6(1):7-15. PubMed ID: 16520291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Explanations and discussions of the revised international federation of gynecology and obstetrics staging system 2009].
    Shen K; Sun JH; Cao ZY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):725-31. PubMed ID: 21176550
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current classification of malignant tumours in gynecological oncology--part II].
    Sehnal B; Driák D; Kmonícková E; Dvorská M; Hosová M; Citterbart K; Halaska M; Kolarík D
    Ceska Gynekol; 2011 Oct; 76(5):360-6. PubMed ID: 22132636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging of uterine sarcomas.
    Tse KY; Crawford R; Ngan HY
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of PET in gynecologic malignancy.
    Grigsby PW
    Curr Opin Oncol; 2009 Sep; 21(5):420-4. PubMed ID: 19553814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.
    Benedetti-Panici P; Maneschi F; D'Andrea G; Cutillo G; Rabitti C; Congiu M; Coronetta F; Capelli A
    Cancer; 2000 May; 88(10):2267-74. PubMed ID: 10820348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sentinel lymph node procedure and uterine cancers].
    Huchon C; Bats AS; Achouri A; Lefrère-Belda MA; Buénerd A; Bensaid C; Farragi M; Mathevet P; Lécuru F
    Gynecol Obstet Fertil; 2010 Dec; 38(12):760-6. PubMed ID: 21111648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas, number 35, May 2002.
    Committee on Practice Bulletins-Gynecology
    Obstet Gynecol; 2002 May; 99(5 Pt 1):855-67. PubMed ID: 11978302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system.
    Petru E; Lück HJ; Stuart G; Gaffney D; Millan D; Vergote I;
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):69-74. PubMed ID: 19195765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features influencing pelvic lymph node metastasis and vaginal and parametrial involvement in patients with carcinoma of the cervix.
    Silva-Filho AL; Reis FM; Traiman P; Pedrosa MS; Miranda D; Triginelli SA
    Gynecol Obstet Invest; 2005; 59(2):92-6. PubMed ID: 15583463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the risk for parametrial involvement in women with early-stage cervical cancer with tumour <20 mm and with negative sentinel lymph nodes?
    Klat J; Sevcik L; Simetka O; Graf P; Dvorackova J; Kraft O
    Aust N Z J Obstet Gynaecol; 2012 Dec; 52(6):540-4. PubMed ID: 23216324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of endometrial adenocarcinoma.
    Barwick TD; Rockall AG; Barton DP; Sohaib SA
    Clin Radiol; 2006 Jul; 61(7):545-55. PubMed ID: 16784939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Status of fractionated abrasion and vaginal endocervical cytology in diagnosis of endometrial cancer].
    Schild R; Kutta T
    Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):467-70. PubMed ID: 1397942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the TNM classification of gynecological tumors].
    Horn LC; Beckmann MW; Beller A; Schmidt D; Ulrich U; Hantschmann P; Wittekind C
    Pathologe; 2010 Sep; 31(5):367-73. PubMed ID: 20844876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.